TXT: Terminating Coverage of Textron Inc.
Key Points We are terminating coverage of Textron Inc. (TXT; previously rated Neutral) due to a change in research focus. Going forward, we will no longer maintain an investment rating ......
ALEMBIC GLOBAL ADVISORS
Alembic Global Advisors is an independent equity research firm offering differentiated, experienced financial analysis on a variety of global industrial sectors. Our goal is to provide high quality, proprietary and actionable research into company, industry and broader macro trends on a truly global level.
Since its founding in 2009, Alembic has expanded from its core global chemical coverage to the aerospace & defense sector. Our analysts have been recognized by industry publications Institutional Investor, FT/Starmine and Extel.We Are
EQUITY RESEARCH ADVISORS
2 research analysts covering 35 companies across 3 industries (Chemicals and Aerospace & Defense). Our coverage list continues to grow as we remain focused on delivering our best-in-class research product.
We Have
VALUABLE INSIGHT
Through our corporate access events we provide unique opportunities to meet with a select group of industry leaders, offering the chance to gain unique insights from people operating at the highest levels of their respective industries.
We Offer
UNIQUE MARKET PERSPECTIVE
In addition to highly analytical deep dive research surrounding our specific equity coverage, we provide our macro view of each industry against the global backdrop of current events and how we see them shaping the future. We leverage our various areas of expertise to produce a collaborative cross-sector research product. This non-siloed approach allows us to maximize our areas of expertise, ultimately achieving a more dynamic and in-depth level of insight.
Get in touch with us to learn more about working with Alembic Global Advisors.
LATEST NEWS
RESEARCH REPORTS
Not a client? Please contact Stephen Matthews – stephen.matthews@alembicglobal.com – to learn more about our research subscription offerings.
Access is limited to Alembic Global Advisors clients.
- April 21, 2026
- April 17, 2026
GD: Updating Forecast Post 4Q, but Maintaining Neutral Rating on Visibility Concerns
Key Points We’re updating our outlook for GD for the first time post the firm’s 4Q earnings results, and we’re maintaining our Neutral rating on the shares. Our target price ......
- April 16, 2026
U.S. Chemicals – In-Line Q1, But 2026 Earnings Power Underappreciated
Key Points Q1 stronger than feared, but already priced in: Solid volumes and PE margin expansion offset ethylene weakness; consensus broadly captures y-o-y earnings decline Earnings upside underappreciated: Product price ......
- April 15, 2026
BA: Updating Forecast Post 1Q O&D; Lowering Target Price but Maintain Overweight Rating
Key Points We’re updating our outlook for BA after yesterday’s release of 1Q26 orders and deliveries data. We’re making minimal changes to our forecast but our target price declines USD13 ......
- April 9, 2026
U.S. Chemicals – Longer Disruption, Stronger Recovery: Upgrading DOW and LYB to O/W
Key Points 8–9 month supply chain normalization keeps markets tight and supports higher-for-longer pricing Elevated oil, North American cost advantages, and accelerating capacity rationalization drive meaningful upside to polyethylene pricing ......
- April 8, 2026
MENA Chemicals – Strong Prices, Weak Realization into Q1 (and 2026) Prints
Key Points Improving chemical pricing being undermined by Middle East outages and logistics constraints, limiting volume realization for the MENA group Expectations appear too high, with likely misses near term ......